Skip to content
Review

Associations of biological aging and biological age acceleration with mortality in patients with cardiorenal syndrome: A prospective cohort study.

Aug 2026 · American Journal of the Medical Sciences · 0 citations · 41 references
Medicine

TL;DR

KDM-BA, KDM-BA, PhenoAge, KDM-BAA, and PhenoAgeAccel are significantly associated with all-cause mortality among the CRS population, with a non-linear relationship observed in cerebrovascular disease.

Abstract

Background

Cardiorenal syndrome (CRS), characterized by cardiac-renal interplay, imposes a substantial clinical burden. Biological aging (BA), a comprehensive indicator for evaluating the overall aging status of an organism, is linked to individual cardiac or renal diseases, while its association with mortality in the CRS population remains unclear.

Methods

We utilized data from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2018. CRS was defined as chronic cardiorenal comorbidities, specifically the coexistence of self-reported cardiovascular disease and calculated chronic kidney disease. BA was calculated using 12 clinical biomarkers, including the Klemera-Doubal method BA (KDM-BA) and Phenotypic Age (PhenoAge). BA acceleration (BAA), quantified as residuals from linear regression of BA on chronological age, includes KDM-BAA and PhenoAge acceleration (PhenoAgeAccel). Cox proportional hazards model and restricted cubic spline were performed to investigate these associations. Results were presented as hazard ratios (HRs) with 95% confidence intervals (CIs).

Results

1,100 CRS participants were included in the final analysis. A 10-year increase in KDM-BA and PhenoAge in CRS participants was associated with 1.14-fold and 1.63-fold higher all-cause mortality risk, respectively. CRS participants with KDM-BAA (HR: 1.40, 95% CI: 1.13-1.73) or PhenoAgeAccel (HR: 1.54, 95% CI: 1.20-1.96) had elevated all-cause mortality risk. Meanwhile, these positive associations were more pronounced in males. Moreover, KDM-BA was associated with mortality from heart disease and cerebrovascular disease in the CRS population, with a non-linear relationship observed in cerebrovascular disease.

Conclusions

As composite indicators for aging, KDM-BA, PhenoAge, KDM-BAA, and PhenoAgeAccel are significantly associated with all-cause mortality among the CRS population. These measures may serve as potential prognostic biomarkers in this population.

View source

Similar papers

Open access Aug 2026

Joint contributions of metabolic dysfunction and biological aging to cardiometabolic multimorbidity and disease progression: a prospective cohort study

TyG BA composites provide a parsimonious summary of combined metabolic-aging burden and improve risk discrimination beyond conventional clinical factors, but should not be interpreted as superior to models retaining TyG and biological age separately.

B. Yang, Q. Chen, S. Yang · 0 citations
Open access Aug 2026

Biological age acceleration and mortality risk among U.S. adults with cardio-kidney-metabolic syndrome, stages 0–3

This study aims to evaluate the associations of Klemera-Doubal Method Biological Age Acceleration (KDM-BAA) and Phenotypic Age Acceleration (PAA) with all-cause and cause-specific mortality in U.S. adults with Cardio-Kidney-Metabolic (CKM) syndrome stages 0–3 and to establish risk prediction models. Data were obtained...

Xiao-Qiang Chen, Yi-Sen Huang, Ying-Xuan Huang et al. · 0 citations
Open access Oct 2026

Association of Combined Cardiometabolic and Muscle Impairment Index with Cardiovascular-Kidney-Metabolic Syndrome Progression Among Middle-Aged and Older Adults: A Prospective Two-Cohort Study

Introduction: Advanced cardiovascular-kidney-metabolic (CKM) syndrome portends poor cardiovascular outcomes. The cardiometabolic index (CMI) and muscle-loss index (MLI) independently reflect metabolic and cardiovascular risk, but their combined effect on CKM syndrome remains unexplored. We aimed to evaluate the associa...

Zi-Shun Liu, Xiao-Ying Ren, Chang Su et al. · 0 citations
Open access Sep 2026

Associations of cardiometabolic burden with cardiovascular disease–death transitions in metabolic dysfunction-associated steatotic liver disease: a prospective cohort study using multistate analysis

Aim To examine the associations of cardiometabolic burden with transitions from CVD-free status to incident CVD, death without prior CVD, and death after CVD among individuals with MASLD, and to further characterize non-linear patterns, temporal variations, and potential contributing factors related to these associatio...

Chuan-Yong Cui, Yi Zhao, Guang-Ji Zhang et al. · 0 citations
Open access Oct 2026

Clinical trajectory and disease progression in patients with cardio-renal-metabolic syndrome: the CaReMap observational study.

BACKGROUND Cardio-renal-metabolic (CRM) syndrome describes the pathophysiological interconnection among diabetes mellitus (DM), atherosclerotic cardiovascular disease (ASCVD) and heart failure (HF), and chronic kidney disease (CKD). Limited studies simultaneously examine progression trajectories across all three condit...

Federico Turoldo, G. Barbati, C. Radesich et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.